Interplay Between Intracellular Iron Dysregulation and SGLT2 in Diabetic Proximal Tubulopathy

Background: Tubulointerstitial abnormalities are a crucial feature of diabetic nephropathy (DN) and a predictor of the progression of renal dysfunction. Ferroptosis, an iron-dependent form of regulated cell death, which involves intracellular iron accumulation, has become increasingly recognized as an important mediator of the pathogenesis of diabetic proximal tubulopathy (DPT), and sodium–glucose transport protein (SGLT)2 inhibition has been demonstrated to ameliorate tubular ferroptosis. The purpose of the present study was to clarify the mechanisms of intracellular iron dysregulation in DPT and explore the involvement of SGLT2 in these processes. Methods: We isolated proximal tubules from control and db/db mice, a model of type 2 DN, and measured the expression of iron import proteins (transferrin receptor 1 [TfR1] and divalent metal transporter 1 [DMT1]) and an iron export protein (ferroportin 1 [FP1]). We also evaluated the binding of iron regulatory protein (IRP) to iron-responsive element (IRE) motifs on the mRNAs for these iron transporters. These facilitate the translation of iron import proteins and inhibit that of iron export proteins by modulating mRNA stability. Finally, we evaluated the effect of SGLT2 inhibition on the intracellular iron regulation in DPT. Results: The proximal tubules from the mice exhibited high expression of TfR1 and DMT1 and low expression of FP1 at the mRNA and protein levels vs. the control mice. These differences in expression were determined at the posttranscriptional level and were associated with modifications of the IRE–binding activity of IRP. SGLT2 inhibition ameliorated the diabetes-induced dysregulation of the iron transporters and posttranscriptional regulation in the proximal tubules. Conclusion: The diabetes-induced proximal tubular dysregulation of iron transporters, which is mediated at least in part through an SGLT2-dependent pathway, could cause intracellular iron sequestration, which may play an important role in the pathophysiology of DTN.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.20259evf5qxf
Primary Topic
Erythropoietin and Anemia Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Interplay Between Intracellular Iron Dysregulation and SGLT2 in Diabetic Proximal Tubulopathy

Masayoshi Nanami, Takahiro Kuragano, M Matsuzaki, Yukiko Hasuike et al.
Journal of the American Society of Nephrology
Erythropoietin and Anemia Treatment
article

Interplay Between Intracellular Iron Dysregulation and SGLT2 in Diabetic Proximal Tubulopathy

Masayoshi Nanami, Takahiro Kuragano, M Matsuzaki, Yukiko Hasuike, Akihiro Kuma, Yasuyuki Mimura
article en

Abstract

Background: Tubulointerstitial abnormalities are a crucial feature of diabetic nephropathy (DN) and a predictor of the progression of renal dysfunction. Ferroptosis, an iron-dependent form of regulated cell death, which involves intracellular iron accumulation, has become increasingly recognized as an important mediator of the pathogenesis of diabetic proximal tubulopathy (DPT), and sodium–glucose transport protein (SGLT)2 inhibition has been demonstrated to ameliorate tubular ferroptosis. The purpose of the present study was to clarify the mechanisms of intracellular iron dysregulation in DPT and explore the involvement of SGLT2 in these processes. Methods: We isolated proximal tubules from control and db/db mice, a model of type 2 DN, and measured the expression of iron import proteins (transferrin receptor 1 [TfR1] and divalent metal transporter 1 [DMT1]) and an iron export protein (ferroportin 1 [FP1]). We also evaluated the binding of iron regulatory protein (IRP) to iron-responsive element (IRE) motifs on the mRNAs for these iron transporters. These facilitate the translation of iron import proteins and inhibit that of iron export proteins by modulating mRNA stability. Finally, we evaluated the effect of SGLT2 inhibition on the intracellular iron regulation in DPT. Results: The proximal tubules from the mice exhibited high expression of TfR1 and DMT1 and low expression of FP1 at the mRNA and protein levels vs. the control mice. These differences in expression were determined at the posttranscriptional level and were associated with modifications of the IRE–binding activity of IRP. SGLT2 inhibition ameliorated the diabetes-induced dysregulation of the iron transporters and posttranscriptional regulation in the proximal tubules. Conclusion: The diabetes-induced proximal tubular dysregulation of iron transporters, which is mediated at least in part through an SGLT2-dependent pathway, could cause intracellular iron sequestration, which may play an important role in the pathophysiology of DTN.

Journal of the American Society of NephrologyVol. 36(10S)
Hyogo Medical University (JP)
Openalex Percentile: Top 62%
Erythropoietin and Anemia Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.